Evoke Pharma, Inc. (EVOK:NASDAQ) closed at $11.00 on December 16, 2025, unchanged on the day. It is trading at its 52-week high of $11.00. Evoke Pharma, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since October 23, 2025, EVOK closed higher on 21 days (8%). Its best day was November 4, 2025 (+132.24%) and its worst was November 3, 2025 (-10.87%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 1 time.
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. The company develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Evoke Pharma, Inc. was founded in 2007 and is headquartered in Solana Beach, California.
Find more stocks like EVOK with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.